Japanese Infrastructure Stock News

TSE:9934
TSE:9934Trade Distributors

Inaba Denki Sangyo (TSE:9934): Assessing Valuation After Buyback, Stock Split, and Dividend Upgrade

Inaba Denki Sangyo (TSE:9934) has rolled out several initiatives that are sure to catch investors' eyes. These include a new share buyback, a stock split, and a boost to its second-quarter dividend. See our latest analysis for Inaba Denki SangyoLtd. Momentum has been steadily building for Inaba Denki SangyoLtd this year, with recent moves like the buyback and stock split adding fuel to a share price that is now up over 21% year-to-date and delivering a 23.9% total shareholder return over the...
TSE:7088
TSE:7088Professional Services

3 Global Stocks That Investors Might Be Undervaluing

In recent weeks, global markets have faced a mix of challenges, including concerns over elevated valuations in tech stocks and the impact of geopolitical events like the U.S. federal government shutdown. Amidst this backdrop, identifying undervalued stocks can be crucial for investors looking to navigate market volatility and capitalize on potential opportunities.
TSE:4536
TSE:4536Pharmaceuticals

MHRA Approval of Ryjunea® Could Be a Game Changer for Santen Pharmaceutical (TSE:4536)

In the past week, Santen Pharmaceutical announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) approved Ryjunea® (low-dose atropine 0.1 mg/ml) as the first licensed treatment to slow the progression of myopia in children, following earlier European Commission approval and launches in Europe. This milestone offers Santen a new opportunity to address the rising prevalence of childhood myopia in the UK and further strengthens its international presence in paediatric...